Healthcare News
Ecnoglutide yields superior, sustained reduction in body weight: Study
For adults with obesity or overweight without diabetes, the novel cyclic adenosine monophosphate-biased glucagon-like peptide 1 receptor agonist known as ecnoglutide yields a superior and sustained reduction in body weight versus placebo
Weighted vests might help older adults meet weight loss goals, but solution for corresponding bone loss still elusive
While weight loss is commonly advised to enhance cardiovascular and joint health in older adults with obesity, it may also lead to bone loss, raising the risk of fractures that can diminish both quality and longevity of life.
Monthly obesity shot shows big weight loss in trial
A monthly dose of a new drug called MariTide helped participants in a phase 2 clinical trial shed about 20% of their body weight over a year, researchers reported Monday in The New England Journal of Medicine.
Study finds patients with interrupted GLP-1 access still achieve significant weight loss
Popular anti-obesity medications continue to be effective for weight loss even when availability and access is interrupted
Head-to-head study shows bariatric surgery superior to GLP-1 drugs for weight loss
Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 receptor agonists semaglutide or tirzepatide
